Gary G. Liversidge

4.8k total citations · 2 hit papers
31 papers, 3.8k citations indexed

About

Gary G. Liversidge is a scholar working on Pharmaceutical Science, Materials Chemistry and Surgery. According to data from OpenAlex, Gary G. Liversidge has authored 31 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmaceutical Science, 5 papers in Materials Chemistry and 4 papers in Surgery. Recurrent topics in Gary G. Liversidge's work include Drug Solubulity and Delivery Systems (12 papers), Advanced Drug Delivery Systems (8 papers) and Crystallization and Solubility Studies (5 papers). Gary G. Liversidge is often cited by papers focused on Drug Solubulity and Delivery Systems (12 papers), Advanced Drug Delivery Systems (8 papers) and Crystallization and Solubility Studies (5 papers). Gary G. Liversidge collaborates with scholars based in United States, United Kingdom and Japan. Gary G. Liversidge's co-authors include Elaine Merisko‐Liversidge, Eugene R. Cooper, Kenneth C. Cundy, Masaaki Odomi, Naoki Kamada, T. Mukai, Toshikiro Kimura, Masateru Miyake, Hajime Toguchi and Kazutaka Higaki and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Applied Physiology and Journal of Controlled Release.

In The Last Decade

Gary G. Liversidge

30 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanosizing: a formulation approach for poorly-water-soluble compounds

2003 1.0k citations Elaine Merisko‐Liversidge, Gary G. Liversidge et al. European Journal of Pharmaceutical Sciences profile →
Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs

1995 579 citations Gary G. Liversidge, Kenneth C. Cundy International Journal of Pharmaceutics profile →

Peers

Gary G. Liversidge

BIOMA

Owen I. Corrigan Ireland

Bernard Van Eerdenbrugh Belgium

Toshikiro Kimura Japan

Kazutaka Higaki Japan

Dominique Duchêne France

Roop K. Khar India

Francesca Maestrelli Italy

Kunikazu Moribe Japan

Marzia Cirri Italy

Elaine Merisko‐Liversidge United States

Owen I. Corrigan Ireland

Gary G. Liversidge

2.0k ×0.8

1.1k ×1.2

509 ×0.7

BIOMA

617 ×0.9

427 ×0.8

Citations per year, relative to Gary G. Liversidge Gary G. Liversidge (= 1×) peers Owen I. Corrigan

Countries citing papers authored by Gary G. Liversidge

Since Specialization

Citations

This map shows the geographic impact of Gary G. Liversidge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary G. Liversidge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary G. Liversidge more than expected).

Fields of papers citing papers by Gary G. Liversidge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary G. Liversidge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary G. Liversidge. The network helps show where Gary G. Liversidge may publish in the future.

Co-authorship network of co-authors of Gary G. Liversidge

This figure shows the co-authorship network connecting the top 25 collaborators of Gary G. Liversidge. A scholar is included among the top collaborators of Gary G. Liversidge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary G. Liversidge. Gary G. Liversidge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gullapalli, Rampurna Prasad, Elaine Merisko‐Liversidge, Erich Goldbach, et al.. (2011). A Formulation Strategy for Gamma Secretase Inhibitor ELND006, a BCS Class II Compound: Development of a Nanosuspension Formulation with Improved Oral Bioavailability and Reduced Food Effects in Dogs. Journal of Pharmaceutical Sciences. 101(4). 1462–1474. 18 indexed citations

Merisko‐Liversidge, Elaine & Gary G. Liversidge. (2011). Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology. Advanced Drug Delivery Reviews. 63(6). 427–440. 478 indexed citations

Kamada, Naoki, Masateru Miyake, Keigo Yamada, et al.. (2008). In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. Journal of Controlled Release. 130(1). 29–37. 58 indexed citations

Merisko‐Liversidge, Elaine, Simon L. McGurk, & Gary G. Liversidge. (2004). Insulin Nanoparticles: A Novel Formulation Approach for Poorly Water Soluble Zn-Insulin. Pharmaceutical Research. 21(9). 1545–1553. 59 indexed citations

Merisko‐Liversidge, Elaine, Gary G. Liversidge, & Eugene R. Cooper. (2003). Nanosizing: a formulation approach for poorly-water-soluble compounds. European Journal of Pharmaceutical Sciences. 18(2). 113–120. 1002 indexed citations breakdown →

Merisko‐Liversidge, Elaine, Pramod P. Sarpotdar, Joseph G. Bruno, et al.. (1996). Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs. Pharmaceutical Research. 13(2). 272–278. 174 indexed citations

Liversidge, Gary G., et al.. (1995). The Electrophoretic Mobility of Tripeptides as a Function of pH and Ionic Strength: Comparison with lontophoretic Flux Data. Pharmaceutical Research. 12(5). 751–755. 8 indexed citations

Liversidge, Gary G. & Kenneth C. Cundy. (1995). Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. International Journal of Pharmaceutics. 125(1). 91–97. 579 indexed citations breakdown →

Eickhoff, W., Gary G. Liversidge, & R. Mutharasan. (1991). Liquid chromatographic analysis of a potential polymeric-pendant drug delivery system for peptides. Journal of Chromatography A. 536(1-2). 255–264. 1 indexed citations

10.

Eisenberg, Eugene, et al.. (1991). Determination of Allopurinol and Oxypurinol in Rat Plasma, Intestinal Wash, and Bile by High-Performance Liquid Chromatography with Electrochemical Detection (HPLC/EC) Following Automated Solid Phase Extraction. Pharmaceutical Research. 8(5). 653–655. 4 indexed citations

11.

Eisenberg, Eugene, et al.. (1990). Simultaneous determination of allopurinol and oxypurinol by liquid chromatography using immobilized xanthine oxidase with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 530(1). 65–73. 9 indexed citations

12.

Liversidge, Gary G., et al.. (1990). Effects of buffer composition on electroosmotic flow in capillary electrophoresis. Journal of Microcolumn Separations. 2(4). 176–180. 137 indexed citations

13.

Liversidge, Gary G., John Dent, & W. Eickhoff. (1989). Influence of Indomethacin Amphoteric Gel on Gastric Ulcerogenicity and Absorption of Indomethacin in Rats. Pharmaceutical Research. 6(1). 44–48. 10 indexed citations

14.

Liversidge, Gary G.. (1989). Rectal route of administration for peptides. Biochemical Society Transactions. 17(5). 942–943. 1 indexed citations

15.

Liversidge, Gary G., et al.. (1988). Nasal delivery of a vasopressin antagonist in dogs. Journal of Applied Physiology. 64(1). 377–383. 3 indexed citations

16.

Grant, David, Gary G. Liversidge, & J.L. Bell. (1983). Influence of physicochemical interactions on the properties of suppositories V. The in vitro release of ketoprofen and metronidazole from various fatty suppository bases and correlations with in vivo plasma levels. International Journal of Pharmaceutics. 14(2-3). 251–262. 6 indexed citations

17.

Liversidge, Gary G. & David Grant. (1983). Influence of Physicochemical Interactions on the Properties of Suppositories, II, Interactions Between the Constituents of Fatty Suppository Bases and Ketoprofen or Metronidazole. Drug Development and Industrial Pharmacy. 9(1-2). 223–246. 6 indexed citations

18.

Liversidge, Gary G., et al.. (1983). Simultaneous analysis of 1-β-d-arabinofuranosylcytosine, 1-β-d-arabinofuranosyluracil and sodium salicylate in biological samples by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 276(2). 375–383. 12 indexed citations

19.

Grant, David, et al.. (1982). Applications of thermal methods of analysis in the pharmaceutical industry. Analytical Proceedings. 19(12). 545–545. 8 indexed citations

20.

Liversidge, Gary G., et al.. (1981). Influence of physicochemical interactions on the properties of suppositories I. Interactions between the constituents of fatty suppository bases. International Journal of Pharmaceutics. 7(3). 211–223. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact